Nevertheless, the putative treatment predictive role of SATB2 should preferably be validated in tumour specimens from randomised, controlled treatment trials and the molecular basis for how SATB2 might modulate the effects of chemotherapy and radiation also remains to be elucidated. Here, SATB2 is linked to neoplasm.